Literature DB >> 25439443

Classification of primary hepatic tumours in the cat.

Renee G H M van Sprundel1, Ted S G A M van den Ingh2, Franco Guscetti3, Olivia Kershaw4, Monique E van Wolferen1, Jan Rothuizen1, Bart Spee5.   

Abstract

Hepatic tumours in dogs have recently been re-classified to follow a revised human classification system that takes account of identified hepatic progenitor cells. This study investigated the presence and relative frequency of morphological types of feline primary hepatic neoplasms and aimed to determine whether a similar new classification scheme could be applied in cats. Feline primary liver tumours (n = 61) were examined histologically and with a series of immunohistochemical markers. Six cases of nodular hyperplasia and 21 tumours of hepatocellular origin were diagnosed. The latter were subdivided into hepatocellular tumours that were well differentiated and had no evidence of metastases (n = 18) and tumours that showed poorly differentiated areas with marked cellular and nuclear pleomorphism and had intrahepatic and, or, distant metastases (n = 3). These malignant feline hepatocellular tumours maintained their hepatocellular characteristics (HepPar-1, MRP2, pCEA positive) and were negative, or only <5% positive, for K19. Twenty-five cholangiocellular tumours were diagnosed and all had intrahepatic and, or, distant metastases. Eight NSE positive small cell carcinomas (carcinoids) were diagnosed and subdivided into small cell carcinomas with HPC characteristics (K19 positive) and neuroendocrine carcinomas (K19 negative). In addition, one squamous cell carcinoma originating from the distal part of the choledochal duct was recognised. Feline primary hepatic neoplasms can be sub-divided into benign and malignant hepatocellular tumours, cholangiocellular carcinomas, small cell carcinomas with HPC characteristics, neuroendocrine carcinomas and squamous cell carcinomas. The marked species difference justifies a specific classification for feline primary hepatic neoplasms.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Classification; Feline; Immunohistochemistry; Liver tumours

Mesh:

Substances:

Year:  2014        PMID: 25439443     DOI: 10.1016/j.tvjl.2014.07.002

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  7 in total

1.  One What? Why GI Researchers Should Know and Care About the One Health Initiative.

Authors:  Rebecca G Wells
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-09-28

2.  Hepatocyte ploidy in cats with and without hepatocellular carcinoma.

Authors:  Jacqueline Post; Ingeborg M Langohr; Cynthia R L Webster; Peter Mottram; Chin-Chi Liu; Andrea Johnston
Journal:  BMC Vet Res       Date:  2021-03-04       Impact factor: 2.741

3.  Hepatocellular Carcinoma in a Free-Ranging Three-Toed Sloth (Bradypus variegatus).

Authors:  Alex Junior Souza de Souza; Andreza Pinheiro Malheiros; Victor Lopes da Silva; Tereza Cristina da Silva; Bruno Cogliati; Lilian Rose Marques de Sá
Journal:  Animals (Basel)       Date:  2022-07-28       Impact factor: 3.231

4.  Severe pericardial effusion in a cat with peritoneopericardial diaphragmatic hernia and incarcerated hepatic sarcoma.

Authors:  Susan V Ciaravolo; Elizabeth Dobson; Rebekah Liffman; Alison Stickney
Journal:  JFMS Open Rep       Date:  2022-09-17

5.  Cellular characteristics of keratin 19-positive canine hepatocellular tumours explain its aggressive behaviour.

Authors:  Renee G van Sprundel; Ted Sgam van den Ingh; Baukje A Schotanus; Monique E van Wolferen; Louis C Penning; Jan Rothuizen; Bart Spee
Journal:  Vet Rec Open       Date:  2017-10-21

6.  Retrospective study of the relative frequency of feline hepatobiliary disease in New Zealand based on 10 years of hepatic biopsy samples.

Authors:  Thomas Fluen; Michael Hardcastle; Helen L Smith; Robyn N A Gear
Journal:  Vet Rec Open       Date:  2019-10-03

7.  Primary intrahepatic squamous cell carcinoma in a sika deer.

Authors:  Kazuya Matsuda; Junji Yamada; Shun Kogame; Ryo Murata; Yuto Sano
Journal:  J Vet Med Sci       Date:  2019-12-11       Impact factor: 1.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.